nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinolazepam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.0119	0.0358	CbGeAlD
Cinolazepam—GABRD—forebrain—attention deficit hyperactivity disorder	0.0104	0.0311	CbGeAlD
Cinolazepam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.01	0.03	CbGeAlD
Cinolazepam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00964	0.0289	CbGeAlD
Cinolazepam—GABRA1—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00877	0.0138	CbGpPWpGaD
Cinolazepam—GABRR2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0084	0.0132	CbGpPWpGaD
Cinolazepam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00777	0.0233	CbGeAlD
Cinolazepam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00732	0.0219	CbGeAlD
Cinolazepam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00732	0.0219	CbGeAlD
Cinolazepam—GABRG3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00692	0.0109	CbGpPWpGaD
Cinolazepam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00686	0.0205	CbGeAlD
Cinolazepam—GABRB1—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00681	0.0107	CbGpPWpGaD
Cinolazepam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00681	0.0204	CbGeAlD
Cinolazepam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00674	0.0202	CbGeAlD
Cinolazepam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00668	0.02	CbGeAlD
Cinolazepam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.0066	0.0198	CbGeAlD
Cinolazepam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00655	0.0196	CbGeAlD
Cinolazepam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00649	0.0194	CbGeAlD
Cinolazepam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00646	0.0194	CbGeAlD
Cinolazepam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.0064	0.0192	CbGeAlD
Cinolazepam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.00634	0.019	CbGeAlD
Cinolazepam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.00625	0.0187	CbGeAlD
Cinolazepam—GABRB2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00582	0.00918	CbGpPWpGaD
Cinolazepam—GABRA5—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00565	0.00892	CbGpPWpGaD
Cinolazepam—GABRD—nervous system—attention deficit hyperactivity disorder	0.00564	0.0169	CbGeAlD
Cinolazepam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00562	0.0168	CbGeAlD
Cinolazepam—GABRA3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00555	0.00876	CbGpPWpGaD
Cinolazepam—GABRA2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00546	0.00861	CbGpPWpGaD
Cinolazepam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.00543	0.0163	CbGeAlD
Cinolazepam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.00543	0.0163	CbGeAlD
Cinolazepam—GABRB3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00542	0.00855	CbGpPWpGaD
Cinolazepam—GABRG2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00532	0.0084	CbGpPWpGaD
Cinolazepam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.00531	0.0159	CbGeAlD
Cinolazepam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.00526	0.0158	CbGeAlD
Cinolazepam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00523	0.0157	CbGeAlD
Cinolazepam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.00522	0.0157	CbGeAlD
Cinolazepam—GABRG3—brain—attention deficit hyperactivity disorder	0.0052	0.0156	CbGeAlD
Cinolazepam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.00511	0.0153	CbGeAlD
Cinolazepam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.00507	0.0152	CbGeAlD
Cinolazepam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00504	0.0151	CbGeAlD
Cinolazepam—GABRR1—brain—attention deficit hyperactivity disorder	0.00496	0.0149	CbGeAlD
Cinolazepam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.00495	0.0148	CbGeAlD
Cinolazepam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00487	0.0146	CbGeAlD
Cinolazepam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00483	0.0145	CbGeAlD
Cinolazepam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00483	0.0145	CbGeAlD
Cinolazepam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00469	0.0141	CbGeAlD
Cinolazepam—GABRA1—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00465	0.00734	CbGpPWpGaD
Cinolazepam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.00463	0.144	CrCbGaD
Cinolazepam—GABRD—brain—attention deficit hyperactivity disorder	0.00431	0.0129	CbGeAlD
Cinolazepam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00427	0.0128	CbGeAlD
Cinolazepam—GABRG1—brain—attention deficit hyperactivity disorder	0.00415	0.0124	CbGeAlD
Cinolazepam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.00409	0.127	CrCbGaD
Cinolazepam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.00409	0.127	CrCbGaD
Cinolazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00405	0.00638	CbGpPWpGaD
Cinolazepam—GABRG3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00403	0.00636	CbGpPWpGaD
Cinolazepam—GABRB1—brain—attention deficit hyperactivity disorder	0.00402	0.0121	CbGeAlD
Cinolazepam—GABRA5—brain—attention deficit hyperactivity disorder	0.004	0.012	CbGeAlD
Cinolazepam—GABRB1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00397	0.00626	CbGpPWpGaD
Cinolazepam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.00397	0.0119	CbGeAlD
Cinolazepam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.00397	0.0119	CbGeAlD
Cinolazepam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.00396	0.123	CrCbGaD
Cinolazepam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.00391	0.122	CrCbGaD
Cinolazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00386	0.00609	CbGpPWpGaD
Cinolazepam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00382	0.0115	CbGeAlD
Cinolazepam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00382	0.0115	CbGeAlD
Cinolazepam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.00379	0.118	CrCbGaD
Cinolazepam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00374	0.0112	CbGeAlD
Cinolazepam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.00374	0.0112	CbGeAlD
Cinolazepam—GABRA3—brain—attention deficit hyperactivity disorder	0.00372	0.0112	CbGeAlD
Cinolazepam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00371	0.0111	CbGeAlD
Cinolazepam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00363	0.0109	CbGeAlD
Cinolazepam—GABRR1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0036	0.00568	CbGpPWpGaD
Cinolazepam—GABRE—nervous system—attention deficit hyperactivity disorder	0.0036	0.0108	CbGeAlD
Cinolazepam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00351	0.0105	CbGeAlD
Cinolazepam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00349	0.0105	CbGeAlD
Cinolazepam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.00346	0.0104	CbGeAlD
Cinolazepam—GABRR2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00344	0.00542	CbGpPWpGaD
Cinolazepam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00341	0.0102	CbGeAlD
Cinolazepam—GABRB2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00339	0.00535	CbGpPWpGaD
Cinolazepam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00338	0.0101	CbGeAlD
Cinolazepam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.0033	0.00989	CbGeAlD
Cinolazepam—GABRA5—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0033	0.0052	CbGpPWpGaD
Cinolazepam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00325	0.101	CrCbGaD
Cinolazepam—GABRA3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00324	0.00511	CbGpPWpGaD
Cinolazepam—GABRA2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00318	0.00502	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00318	0.00501	CbGpPWpGaD
Cinolazepam—GABRB3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00316	0.00499	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00313	0.00494	CbGpPWpGaD
Cinolazepam—GABRG2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0031	0.0049	CbGpPWpGaD
Cinolazepam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00305	0.00914	CbGeAlD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00304	0.0048	CbGpPWpGaD
Cinolazepam—GABRG2—brain—attention deficit hyperactivity disorder	0.00304	0.0091	CbGeAlD
Cinolazepam—GABRB2—brain—attention deficit hyperactivity disorder	0.00304	0.0091	CbGeAlD
Cinolazepam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.00294	0.0088	CbGeAlD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0029	0.00458	CbGpPWpGaD
Cinolazepam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00287	0.0086	CbGeAlD
Cinolazepam—GABRG3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00283	0.00446	CbGpPWpGaD
Cinolazepam—GABRB1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00279	0.00439	CbGpPWpGaD
Cinolazepam—GABRA2—brain—attention deficit hyperactivity disorder	0.00277	0.00831	CbGeAlD
Cinolazepam—GABRE—brain—attention deficit hyperactivity disorder	0.00275	0.00824	CbGeAlD
Cinolazepam—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00271	0.00428	CbGpPWpGaD
Cinolazepam—GABRR2—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.0027	0.00426	CbGpPWpGaD
Cinolazepam—GABRA1—brain—attention deficit hyperactivity disorder	0.00268	0.00803	CbGeAlD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00268	0.00422	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0026	0.0041	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00255	0.00403	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00251	0.00396	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00249	0.00393	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00245	0.00386	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00239	0.00377	CbGpPWpGaD
Cinolazepam—GABRB2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00238	0.00376	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00235	0.00371	CbGpPWpGaD
Cinolazepam—GABRB3—brain—attention deficit hyperactivity disorder	0.00233	0.00699	CbGeAlD
Cinolazepam—GABRR1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00233	0.00368	CbGpPWpGaD
Cinolazepam—GABRA5—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00231	0.00365	CbGpPWpGaD
Cinolazepam—GABRA3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00227	0.00358	CbGpPWpGaD
Cinolazepam—GABRA2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00223	0.00352	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00222	0.00351	CbGpPWpGaD
Cinolazepam—GABRB3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00222	0.0035	CbGpPWpGaD
Cinolazepam—GABRG2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00218	0.00343	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00214	0.00337	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00201	0.00317	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00195	0.00308	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00192	0.00303	CbGpPWpGaD
Cinolazepam—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0019	0.003	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00189	0.00297	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00187	0.00295	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00184	0.0029	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00183	0.00289	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0018	0.00284	CbGpPWpGaD
Cinolazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00178	0.00281	CbGpPWpGaD
Cinolazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0017	0.00268	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00161	0.00254	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00156	0.00246	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00154	0.00243	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0015	0.00236	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00149	0.00234	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00147	0.00232	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00145	0.00228	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00144	0.00226	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00141	0.00222	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0014	0.00221	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00138	0.00217	CbGpPWpGaD
Cinolazepam—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.00137	0.0426	CrCbGaD
Cinolazepam—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.00134	0.0418	CrCbGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00134	0.00211	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00131	0.00207	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00128	0.00201	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00125	0.00198	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00125	0.00198	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00125	0.00196	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00123	0.00194	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00122	0.00193	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00121	0.0019	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0012	0.00189	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00119	0.00188	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00119	0.00187	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00118	0.00186	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00114	0.0018	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00114	0.0018	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00112	0.00177	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00111	0.00175	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0011	0.00174	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0011	0.00173	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00108	0.0017	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00106	0.00167	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00105	0.00166	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00104	0.00163	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00103	0.00163	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00103	0.00162	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00103	0.00162	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00102	0.0016	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.001	0.00158	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.001	0.00158	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000985	0.00155	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000982	0.00155	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000979	0.00154	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000978	0.00154	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00097	0.00153	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000966	0.00152	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000963	0.00152	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000959	0.00151	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000954	0.0015	CbGpPWpGaD
Cinolazepam—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000946	0.0295	CrCbGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000944	0.00149	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000942	0.00149	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000942	0.00149	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000937	0.00148	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000937	0.00148	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000923	0.00146	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00091	0.00144	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.0009	0.00142	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000894	0.00141	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000886	0.0014	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000872	0.00137	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000869	0.00137	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000864	0.00136	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00086	0.00136	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000859	0.00135	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00085	0.00134	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000845	0.00133	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000844	0.00133	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00083	0.00131	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000829	0.00131	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000829	0.00131	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000825	0.0013	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000823	0.0013	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000823	0.0013	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000814	0.00128	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000811	0.00128	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00081	0.00128	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000809	0.00128	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000806	0.00127	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000805	0.00127	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000803	0.00127	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000803	0.00127	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0008	0.00126	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000795	0.00125	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000794	0.00125	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000791	0.00125	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000789	0.00124	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000785	0.00124	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000777	0.00123	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000772	0.00122	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000772	0.00122	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000767	0.00121	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000767	0.00121	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000758	0.0012	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000753	0.00119	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000753	0.00119	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000749	0.00118	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000741	0.00117	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00074	0.00117	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000738	0.00116	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000736	0.00116	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000735	0.00116	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000734	0.00116	CbGpPWpGaD
Cinolazepam—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.000731	0.0228	CrCbGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00073	0.00115	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000725	0.00114	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000724	0.00114	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000723	0.00114	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000722	0.00114	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000718	0.00113	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000713	0.00112	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000708	0.00112	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0007	0.0011	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000695	0.0011	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00069	0.00109	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000688	0.00108	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000685	0.00108	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000683	0.00108	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000679	0.00107	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000671	0.00106	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000668	0.00105	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000663	0.00104	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000659	0.00104	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000658	0.00104	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000658	0.00104	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000647	0.00102	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000636	0.001	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000632	0.000997	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000631	0.000995	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000631	0.000995	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000624	0.000984	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000621	0.000979	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00062	0.000977	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000613	0.000966	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000606	0.000956	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000604	0.000953	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000602	0.000949	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000602	0.000949	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000595	0.000939	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000591	0.000933	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000591	0.000932	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000588	0.000927	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000587	0.000925	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000585	0.000923	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000583	0.000919	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000581	0.000916	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000581	0.000916	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000577	0.00091	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000577	0.00091	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000571	0.0009	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000568	0.000896	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000567	0.000894	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000564	0.000889	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000562	0.000887	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000559	0.000882	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000556	0.000876	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000546	0.000861	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000542	0.000855	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000536	0.000846	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000527	0.000831	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000524	0.000826	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000514	0.000811	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000504	0.000795	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000499	0.000787	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000495	0.000781	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000493	0.000777	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000478	0.000754	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000475	0.000749	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000464	0.000732	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000461	0.000727	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000457	0.000721	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000456	0.000719	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000453	0.000714	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000449	0.000709	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000448	0.000707	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000445	0.000702	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000445	0.000702	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000442	0.000697	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000437	0.00069	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000436	0.000688	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000434	0.000685	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000382	0.000603	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000379	0.000598	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000359	0.000566	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000354	0.000558	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000302	0.000477	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000294	0.000463	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000288	0.000455	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000283	0.000447	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000282	0.000444	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000276	0.000436	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000261	0.000412	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000242	0.000381	CbGpPWpGaD
